MENU
+Compare
BFRI
Stock ticker: NASDAQ
AS OF
Jun 13 closing price
Price
$0.66
Change
+$0.01 (+1.54%)
Capitalization
9.77M

BFRI Biofrontera Forecast, Technical & Fundamental Analysis

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy... Show more

BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BFRI with price predictions
Jun 13, 2025

BFRI's RSI Indicator ascends from oversold territory

The RSI Indicator for BFRI moved out of oversold territory on June 03, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In of the 25 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 43 cases where BFRI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 11, 2025. You may want to consider a long position or call options on BFRI as a result. In of 58 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BFRI just turned positive on June 03, 2025. Looking at past instances where BFRI's MACD turned positive, the stock continued to rise in of 29 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BFRI advanced for three days, in of 156 cases, the price rose further within the following month. The odds of a continued upward trend are .

BFRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFRI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BFRI entered a downward trend on June 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.039) is normal, around the industry mean (62.115). P/E Ratio (0.000) is within average values for comparable stocks, (88.968). BFRI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (0.087) is also within normal values, averaging (19.096).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BFRI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BFRI is expected to report earnings to rise 22.22% to -21 cents per share on August 11

Biofrontera BFRI Stock Earnings Reports
Q2'23
Est.
$-0.22
Q4'24
Beat
by $0.02
Q1'23
Missed
by $0.20
Q4'22
Missed
by $0.04
Q3'22
Beat
by $0.18
The last earnings report on March 20 showed earnings per share of -18 cents, beating the estimate of -20 cents. With 151.60K shares outstanding, the current market capitalization sits at 9.77M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
120 Presidential Way
Phone
+1 781 245-1325
Employees
85
Web
https://www.biofrontera-us.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SFWL0.990.02
+2.06%
Shengfeng Development Limited
NPK95.27-0.32
-0.33%
National Presto Industries
CNH12.57-0.21
-1.64%
CNH Industrial NV
TEO9.43-0.41
-4.17%
Telecom Argentina SA
TRAW1.69-0.11
-6.11%
Traws Pharma Inc

BFRI and Stocks

Correlation & Price change

A.I.dvisor tells us that BFRI and CRON have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
+1.38%
CRON - BFRI
21%
Poorly correlated
-3.02%
COLL - BFRI
21%
Poorly correlated
-1.42%
PLSH - BFRI
17%
Poorly correlated
-2.27%
SHPH - BFRI
15%
Poorly correlated
-9.35%
CRDL - BFRI
12%
Poorly correlated
+1.39%
More

Groups containing BFRI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
+1.38%
Pharmaceuticals
category (298 stocks)
5%
Poorly correlated
-0.14%